| Identification | More | [Name]
Testosterone acetate | [CAS]
1045-69-8 | [Synonyms]
17BETA-ACETOXY-4-ANDROSTEN-3-ONE
17BETA-HYDROXY-4-ANDROSTEN-3-ONE 17-ACETATE
17B-HYDROXY-4-ANDROSTEN-3-ONEACETATE
4-ANDROSTEN-17BETA-OL-3-ONE 17-ACETATE
4-ANDROSTEN-17-BETA-OL-3-ONE ACETATE
DELTA-ANDROSTENE-17B-ACETATE-3-ONE
DEPOSTERON
TESTOSTERON 17-ACETATE
TESTOSTERONE 17-ACETATE
TESTOSTERONE ACETATE
17-[(1-Oxoacetyl)oxy]androst-4-en-3-one
17-beta-(acetyloxy)androst-4-en-3-one
17beta-Acetoxy-DELTA4-androstan-3-one
17beta-Acetoxy-delta4-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one acetate
3-Oxoandrost-4-en-17beta-yl acetate
3-Oxoandrost-4-en-17-yl acetate
Aceto-sterandryl
Aceto-testoviron
Amolisin | [EINECS(EC#)]
213-876-6 | [Molecular Formula]
C21H30O3 | [MDL Number]
MFCD00021154 | [Molecular Weight]
330.46 | [MOL File]
1045-69-8.mol |
| Chemical Properties | Back Directory | [Melting point ]
139-141 °C
| [Boiling point ]
427.89°C (rough estimate) | [density ]
1.0234 (rough estimate) | [refractive index ]
1.6000 (estimate) | [Fp ]
2℃ | [storage temp. ]
Controlled Substance, -20°C Freezer | [solubility ]
Acetonitrile: 1 mg/ml; Ethanol: 1 mg/ml; Methanol: 1 mg/ml | [form ]
A crystalline solid | [Water Solubility ]
2.35mg/L(25 ºC) | [Merck ]
13,9255 | [InChI]
InChI=1/C21H30O3/c1-13(22)24-19-7-6-17-16-5-4-14-12-15(23)8-10-20(14,2)18(16)9-11-21(17,19)3/h12,16-19H,4-11H2,1-3H3/t16-,17-,18-,19-,20-,21-/s3 | [InChIKey]
DJPZSBANTAQNFN-PXQJOHHUSA-N | [SMILES]
[C@]12([H])CC[C@]3(C)[C@H](CC[C@@]3([H])[C@]1([H])CCC1=CC(=O)CC[C@]21C)OC(=O)C |&1:0,4,6,9,11,21,r| | [CAS DataBase Reference]
1045-69-8(CAS DataBase Reference) | [NIST Chemistry Reference]
Androst-4-en-3-one, 17-(acetyloxy)-, (17«beta»)-(1045-69-8) |
| Safety Data | Back Directory | [Symbol(GHS) ]
 
GHS02,GHS07 | [Signal word ]
Danger | [Hazard statements ]
H225-H302+H332-H319 | [Precautionary statements ]
P210-P305+P351+P338 | [Hazard Codes ]
T | [Risk Statements ]
R45:May cause cancer.
R22:Harmful if swallowed.
R63:Possible risk of harm to the unborn child. | [Safety Statements ]
S53:Avoid exposure-obtain special instruction before use .
S22:Do not breathe dust .
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36:Wear suitable protective clothing . | [RIDADR ]
UN 2811 6.1/PG 2
| [WGK Germany ]
3
| [RTECS ]
XA3061500
|
| Hazard Information | Back Directory | [Description]
Testosterone acetate (Item No. 26915) is an analytical reference standard categorized as an anabolic androgenic steroid.1,2 It is an ester of the naturally occurring androgen, testosterone (Item Nos. 15645 | ISO60154). Testosterone acetate is regulated as a Schedule III compound in the United States. This product is intended for research and forensic applications. | [Chemical Properties]
White Solid | [Uses]
An Androgen.
Controlled substance. | [Definition]
ChEBI: An androstanoid that is the acetate derivative of testosterone. | [Synthesis]
A solution of 4.23 g (14.7 mmol) of testosterone in 8 ml of pyridine dried over potassium hydroxide overnight (5 g of KOH to 250 ml of pyridine) is prepared in a 250-ml flask equipped with magnetic stirring. The solution is cooled to 0° C. with a water/ice mixture. 4 ml of acetic anhydride is added to it dropwise. The reaction mixture is left to return to room temperature, and the solution is stirred overnight at RT. After the starting product is no longer found in analytical TLC, 30 ml of distilled water and 30 ml of ethyl acetate are poured into the flask, and the mixture is stirred. The phases are separated with a separating funnel, and the aqueous phase is extracted with 3×20 ml of ethyl acetate. The organic phases are combined, and the solution obtained is washed with 20 nil of distilled water, dried over anhydrous magnesium sulfate, and evaporated in a rotary evaporator. The product thus obtained is dried under reduced pressure using a vacuum pump for 4 hours to remove all the solvents. 4.8 g (yield=99.0%) of testosterone acetate is obtained.
 | [General Description]
Testosterone acetate is an androgen ester and an intermediate in the synthesis of testosterone from progesterone, isolated from microorganisms. | [References]
[1] LAURA TRETZEL . Use of dried blood spots in doping control analysis of anabolic steroid esters[J]. Journal of pharmaceutical and biomedical analysis, 2014, 96: Pages 21-30. DOI: 10.1016/j.jpba.2014.03.013
[2] GURO FORSDAHL. Detection of testosterone esters in blood[J]. Drug Testing and Analysis, 2015, 7 11-12: 983-989. DOI: 10.1002/dta.1914 |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
400-0056266 |
| Website: |
www.energy-chemical.com |
| Company Name: |
Spectrum Chemical Manufacturing Corp.
|
| Telephone: |
021-021-021-67601398-809-809-809 15221380277 |
| Website: |
www.spectrumchemical.com/oa_html/index.jsp?minisite=10020&respid=22372&language=us |
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Telephone: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.chemicalbook.com/ShowSupplierProductsList15748/0_EN.htm |
| Company Name: |
LETOPHARM LIMITED
|
| Telephone: |
+86-21-5821 5861 |
| Website: |
www.letopharm.com |
|